# Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation

> **NCT00856505** · PHASE1,PHASE2 · UNKNOWN · sponsor: **University Hospital Freiburg** · enrollment: 38 (estimated)

## Conditions studied

- Hematologic Diseases

## Interventions

- **DRUG:** Everolimus and mycophenolate sodium

## Key facts

- **NCT ID:** NCT00856505
- **Lead sponsor:** University Hospital Freiburg
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2008-03
- **Primary completion:** 2010-03
- **Final completion:** 2011-03
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2009-03-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00856505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00856505, "Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00856505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*